BrightWater Medical
Medical devices that focus on treatments for ureteral blockages by interventional radiologists.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
$35.0m Valuation: $35.0m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
BrightWater Medical specializes in developing advanced medical devices for treating severe ureteral and biliary obstructions. Their flagship product, the ConvertX Stent Family, is unique in that it can convert to an internal stent without requiring a second interventional procedure, significantly reducing patient risk and healthcare costs. The ConvertX Biliary System is also the first to offer a percutaneous plastic biliary stent option, providing interventional radiologists with a new tool for patient care.
The company primarily serves healthcare providers, including urologists and interventional radiologists, operating in the medical device market. BrightWater Medical's business model revolves around the sale of its proprietary stent systems to hospitals and clinics, generating revenue through direct sales and partnerships.
Keywords: ureteral obstruction, biliary obstruction, ConvertX Stent, medical devices, interventional radiology, urology, healthcare innovation, patient care, cost reduction, proprietary technology.